| Literature DB >> 35331712 |
Peyton Presto1, Mariacristina Mazzitelli1, Riley Junell1, Zach Griffin1, Volker Neugebauer2.
Abstract
Despite the overwhelming female-predominance in chronic pain disorders, preclinical pain studies have historically excluded females as research subjects. Male-biased explanations of pathological pain mechanisms may not fully translate to pain processes in females, necessitating the exploration of pain processing and modulation in both sexes at the preclinical and clinical levels. This review highlights historical trends in the study of sex differences within the pain field and examines the current literature regarding new techniques for the mechanistic analysis of pain modulation in males and females. A large body of evidence suggests that sex differences exist at the molecular, cellular, and systems levels of pain processing, likely influenced by a combination of genetic, hormonal, and neuroimmune factors that may differ at distinct levels of the neuraxis.Entities:
Keywords: Behavior; Neuroimmune signaling; Neurophysiology; Pain; Sex differences; Transcriptomics
Mesh:
Year: 2022 PMID: 35331712 PMCID: PMC9354808 DOI: 10.1016/j.neuropharm.2022.109030
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.273